Evonik and Ethris Forge Strategic Alliance to Redefine Nucleic Acid Delivery with Novel Lipid Nanoparticle Platform In a move that underscores the rapid evolution of nucleic acid-based medicines and the growing importance of advanced drug delivery technologies, Evonik, a global…
Alnylam Pharmaceuticals Launches $500 Million Convertible Senior Notes Offering to Strengthen Strategic Flexibility and Advance RNAi Pipeline Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the biotechnology pioneer recognized worldwide as the leader in RNA interference (RNAi) therapeutics, has announced the commencement of…
Amazon Pharmacy Expands $5 RxPass Subscription Service to Texas, Offering Affordable Medication Access for Millions Amazon Pharmacy, the digital healthcare arm of Amazon, announced today that it is expanding RxPass, its flat-fee monthly prescription service, to Texas. This move marks…
Aptar Pharma and Dianosic Forge Exclusive Partnership to Advance Resorbable Intranasal Scaffold Technology for Chronic Rhinitis, Sinusitis, and Beyond In a strategic move that underscores the growing importance of patient-centric intranasal drug delivery platforms, Aptar Pharma, a global leader in…
WHO Expands Essential Medicines Lists to Include Landmark Treatments for Cancer, Diabetes, and Other Major Disease The World Health Organization (WHO) has announced a major update to its Model Lists of Essential Medicines (EML) and the Essential Medicines for Children…
Gilead Partners With PEPFAR and Global Fund to Deliver Twice-Yearly Lenacapavir for HIV Prevention Across Low- and Lower-Middle-Income Countries Gilead Sciences, Inc. (Nasdaq: GILD) has announced a major new global partnership with the U.S. State Department, the United States President’s…
MRM Health Secures €55 Million Series B Financing to Accelerate Development of Best-in-Class Microbiome-Based Biotherapeutics MRM Health NV, a pioneering clinical-stage biopharmaceutical company developing transformative microbiome-based therapeutics, announced the successful closing of a €55 million (approximately US$64 million) Series B…
MEDIPAL Holdings and JCR Pharmaceuticals Expand Rare Disease Collaboration with Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Investigational Therapy for GM2 Gangliosidosis In a significant advancement for patients and families affected by ultra-rare lysosomal storage disorders, MEDIPAL…
Neurotech Pharmaceuticals Strengthens Leadership with Appointment of Dr. Peter J. McDonnell to Board of Directors Neurotech Pharmaceuticals, Inc., a privately held biotechnology company pioneering transformative therapies for chronic eye diseases, today announced the appointment of Peter J. McDonnell, M.D., a…
Enlaza Therapeutics and Vertex Pharmaceuticals Forge Multi-Billion-Dollar Collaboration to Advance Next-Generation Covalent Biologics in Autoimmune Diseases and Conditioning Therapies Enlaza Therapeutics (“Enlaza” or the “Company”), a pioneering biotechnology firm and the first company to build a dedicated covalent biologics platform,…
Daiichi Sankyo Advances Cardiovascular Care with Development of Oral Triple Combination Lipid-Lowering Tablets A New Chapter in Cholesterol Management Daiichi Sankyo Europe has unveiled an ambitious new initiative: the development of innovative oral triple combination tablets designed to help patients…
Bristol Myers Squibb Showcases Landmark Real-World Data on Camzyos in Obstructive Hypertrophic Cardiomyopathy at ESC Congress 2025 Bristol Myers Squibb (NYSE: BMY) unveiled new results from its global COLLIGO-HCM study at the European Society of Cardiology (ESC) Congress 2025 in…